Silo Pharma’s QwikAgents Joins NVIDIA Program to Enhance AI Agent Platform
SILO•Silo Pharma’s subsidiary QwikAgents joined the NVIDIA Developer Program to access AI software ecosystem resources, development frameworks and optimization tools for its autonomous enterprise AI agent platform. The platform, featuring persistent memory, multi-model routing, browser automation and secure data management, aims to accelerate enhancements and scalability for enterprise workflow automation.
1. Strategic Partnership with NVIDIA
QwikAgents has joined the NVIDIA Developer Program to utilize AI software ecosystem tools, development frameworks, technical training and optimization resources. This collaboration is intended to accelerate the development and deployment of autonomous AI agents within the enterprise AI agent platform.
2. QwikAgents Platform Capabilities
The AI agent platform automates complex workflows through autonomous agents capable of reasoning and interacting with business systems. It features persistent memory, intelligent routing across eight large language model providers, browser automation and secure data management to support scalable AI-driven operations.
3. Expansion Plans for Enterprise Adoption
Access to NVIDIA’s AI ecosystem is expected to fast-track platform enhancements and enable QwikAgents to broaden its service offerings for enterprise customers. Key targets include finance, healthcare and logistics sectors seeking to integrate AI agents for workflow automation.
4. Diversification Strategy within Silo Pharma
This technology partnership complements Silo Pharma’s core biopharmaceutical research and development efforts, marking a strategic diversification into the multi-billion-dollar AI agent market. The move aims to create new revenue streams and leverage emerging AI capabilities alongside its therapeutic pipeline.
